{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:01:46Z","timestamp":1789603306967,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A6A1A03042854"],"award-info":[{"award-number":["NRF-2020R1A6A1A03042854"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C2007159"],"award-info":[{"award-number":["NRF-2021R1A2C2007159"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["- RS-2024-00397929"],"award-info":[{"award-number":["- RS-2024-00397929"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["- RS-2024-00333784"],"award-info":[{"award-number":["- RS-2024-00333784"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2024.117209","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T19:44:21Z","timestamp":1736019861000},"page":"117209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Targeting JNK3 for Alzheimer's disease: Design and synthesis of novel inhibitors with aryl group diversity utilizing wide pocket"],"prefix":"10.1016","volume":"285","author":[{"given":"Hyejin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haebeen","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonhong","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil P.","family":"Bhujbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6439-0405","authenticated-orcid":false,"given":"Jung-Mi","family":"Hah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2024.117209_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-210105","article-title":"Agitation in dementia: real-world impact and burden on patients and the healthcare system","volume":"83","author":"J Jones","year":"2021","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.ejmech.2024.117209_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2024.117209_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.117209_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/hmg\/ddq160","article-title":"Molecular mechanisms of neurodegeneration in Alzheimer's disease","volume":"19","author":"Crews","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2024.117209_bib5a","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.bbamcr.2006.12.009","article-title":"The c-jun kinase\/stress-activated pathway: regulation, function and role in human disease","volume":"1773","author":"Johnson","year":"2007","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.ejmech.2024.117209_bib5b","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105090","article-title":"Map kinase signaling as therapeutic target for neurodegeneration","volume":"160","author":"Ahmed","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.117209_bib6a","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/153331750201700209","article-title":"The JNK\/c-Jun cascade and Alzheimer's disease","volume":"17","author":"Okazawa","year":"2002","journal-title":"Am. J. Alzheimer's Dis. Other Dementias"},{"issue":"10","key":"10.1016\/j.ejmech.2024.117209_bib6b","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3390\/cells9102190","article-title":"JNK3 as therapeutic target and biomarker in neurodegenerative and neurodevelopmental brain diseases","volume":"9","author":"Musi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2024.117209_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.nbd.2008.12.014","article-title":"JNK regulates APP cleavage and degradation in a model of Alzheimer's disease","volume":"33","author":"Colombo","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2024.117209_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/alz.12370","article-title":"Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases","volume":"18","author":"Zhao","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ejmech.2024.117209_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fphar.2015.00321","article-title":"c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer's disease","volume":"6","author":"Yarza","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117209_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0896-6273(00)80727-8","article-title":"The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development","volume":"22","author":"Kuan","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2024.117209_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1471-4159.2001.00400.x","article-title":"JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympathetic neurons","volume":"78","author":"Bruckner","year":"2001","journal-title":"J. Neurochem."},{"issue":"23","key":"10.1016\/j.ejmech.2024.117209_bib12","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1523\/JNEUROSCI.4883-04.2005","article-title":"Physiological regulation of the \u03b2-amyloid precursor protein signaling domain by c-jun N-terminal kinase JNK3 during neuronal differentiation","volume":"25","author":"Kimberly","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2024.117209_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/39899","article-title":"Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene","volume":"389","author":"Derek","year":"1997","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejmech.2024.117209_bib14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neuron.2012.06.024","article-title":"JNK3 perpetuates metabolic stress induced by A\u03b2 peptides","volume":"75","author":"Yoon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2024.117209_bib15","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1046\/j.1471-4159.1997.68041736.x","article-title":"Stress-activated protein kinase\/c-jun N-terminal kinase phosphorylates \u03c4 protein","volume":"68","author":"Reynolds","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2024.117209_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrd1132","article-title":"Targeting JNK for therapeutic benefit: from junk to gold","volume":"2","author":"Manning","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.117209_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbapap.2007.09.013","article-title":"Inhibitors of c-Jun N-terminal kinases: JuNK no more?","volume":"1784","author":"Bogoyevitch","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2024.117209_bib18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1471-4159.2000.0741587.x","article-title":"Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta","volume":"74","author":"Reynolds","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2024.117209_bib19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1471-4159.2004.02479.x","article-title":"Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun Nterminal kinase (JNK)","volume":"90","author":"Yoshida","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2024.117209_bib20","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1523\/JNEUROSCI.22-09-03376.2002","article-title":"Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition","volume":"22","author":"Savage","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2024.117209_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/NEN.0b013e3182456aed","article-title":"Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice","volume":"71","author":"Tran","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"9","key":"10.1016\/j.ejmech.2024.117209_bib22","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1021\/acs.jmedchem.3c00393","article-title":"Carbamate JNK3 inhibitors show promise as effective treatments for Alzheimer's disease: in vivo studies on mouse models","volume":"66","author":"Jun","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117209_bib23","doi-asserted-by":"crossref","first-page":"114894","DOI":"10.1016\/j.ejmech.2022.114894","article-title":"Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease","volume":"245","author":"Jun","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117209_bib24","doi-asserted-by":"crossref","first-page":"114917","DOI":"10.1016\/j.ejmech.2022.114917","article-title":"Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases","volume":"245","author":"Jun","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2024.117209_bib25","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.bmc.2013.02.021","article-title":"Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects","volume":"21","author":"Kim","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117209_bib26","doi-asserted-by":"crossref","first-page":"11084","DOI":"10.3390\/ijms222011084","article-title":"Discovery of a potent and selective JNK3 inhibitor with neuroprotective effect against amyloid \u03b2-induced neurotoxicity in primary rat neurons","volume":"22","author":"Jun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.117209_bib27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/14756366.2019.1705294","article-title":"Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1H-pyrazole derivatives as a novel selective inhibitor scaffold of JNK3","volume":"35","author":"Oh","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117209_bib28","doi-asserted-by":"crossref","unstructured":"Han, B. G.; Shim, M. B.; Ahn, H. C. The Crystal Structure of Inhibitor-Bound JNK3 PDB DOI: 10.2210\/pdb4KKH\/pdb.","DOI":"10.2210\/pdb4kkh\/pdb"},{"issue":"9","key":"10.1016\/j.ejmech.2024.117209_bib29","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s12039-016-1142-9","article-title":"A new class of efficient 4-[(nitrosubstituted-phenyl)-hydrazonomethyl]-1-phenyl-1H-pyrazole-3-carboxylate derived colorimetric chemosensor for selective sensing of fluoride and other biologically important anions","volume":"128","author":"Swami","year":"2016","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.ejmech.2024.117209_bib30","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/chem.201304336","article-title":"Trifluoroacetic acid in 2,2,2-Trifluoroethanol facilitates SNAr reactions of heterocycles with arylamines","volume":"20","author":"Carbain","year":"2014","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2024.117209_bib31","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/jm060199b","article-title":"Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity","volume":"49","author":"Szczepankiewicz","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117209_bib32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.ejmech.2024.117209_bib33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1074-5521(03)00159-5","article-title":"The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity","volume":"10","author":"Scapin","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.117209_bib34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1021\/acs.jcim.8b00222","article-title":"Determination of a focused mini kinase panel for early identification of selective kinase inhibitors","volume":"58","author":"Bembenek","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2024.117209_bib35","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1021\/acsomega.8b00668","article-title":"Structural optimization of a pyridinylimidazole scaffold: shifting the selectivity from p38\u03b1 mitogen-activated protein kinase to c-jun N-terminal kinase 3","volume":"3","author":"Ansideri","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.117209_bib36","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bjp.0705688","article-title":"Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C","volume":"141","author":"Han","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117209_bib37","first-page":"2015","article-title":"A\u03b21-42 regulates astrocytes through JNK\/AP-1 pathway","volume":"22","author":"Li","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.117209_bib38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neuron.2012.06.024","article-title":"JNK3 perpetuates metabolic stress induced by A\u03b2 peptides","volume":"75","author":"Yoon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2024.117209_bib39","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1523\/JNEUROSCI.21-19-07551.2001","article-title":"\u03b2-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand","volume":"21","author":"Morishima","year":"2001","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.ejmech.2024.117209_bib40a","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2174\/138920008786485227","article-title":"Artificial membrane assays to assess permeability","volume":"9","author":"Faller","year":"2008","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2024.117209_bib40b","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1087057105281656","article-title":"Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography","author":"Yoon","year":"2006","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2024.117209_bib41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/0471141755.ph0706s19","article-title":"Determination of the stability of drugs in plasma","volume":"19","author":"Hartman","year":"2002","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117209_bib42","series-title":"Structure Design and Methods from ADME to Toxicity Optimization","article-title":"Drug-like properties: concepts","author":"Kerns","year":"2008"},{"issue":"3","key":"10.1016\/j.ejmech.2024.117209_bib43","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/acs.jmedchem.2c01767","article-title":"Chemical optimization of CBL0137 for human African Trypanosomiasis lead drug discovery","volume":"66","author":"Singh","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:07:20Z","timestamp":1777529240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424010912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":46,"alternative-id":["S0223523424010912"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117209","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting JNK3 for Alzheimer's disease: Design and synthesis of novel inhibitors with aryl group diversity utilizing wide pocket","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117209"}}